Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?

Objective. In accordance with clinical guidelines, neoadjuvant chemoradiotherapy (nCRT) is recommended as a beneficial option for treatment of thoracic esophageal squamous cell carcinoma (TESCC). However, some studies did not demonstrate potential benefits of nCRT. In this paper we compared treatmen...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	D. A. Chichevatov, E. N. Sinev, A. E. Glukhov, O. M. Seliverstova
Aineistotyyppi:	Artigo
Kieli:	Russo
Julkaistu:	Russian Academy of Sciences, Tomsk National Research Medical Center 2024-05-01
Sarja:	Сибирский онкологический журнал
Aiheet:	squamous cell esophageal carcinoma chemoradiation therapy surgery
Linkit:	https://www.siboncoj.ru/jour/article/view/3034
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!